61 related articles for article (PubMed ID: 9251095)
1. Stability of levodopa/carbidopa solutions.
Cedarbaum JM
Mov Disord; 1997 Jul; 12(4):625. PubMed ID: 9251095
[No Abstract] [Full Text] [Related]
2. The stability of carbidopa in solution.
Pappert EJ; Lipton JW; Goetz CG; Ling ZD; Stebbins GT; Carvey PM
Mov Disord; 1997 Jul; 12(4):608-10. PubMed ID: 9251084
[No Abstract] [Full Text] [Related]
3. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use.
Pappert EJ; Buhrfiend C; Lipton JW; Carvey PM; Stebbins GT; Goetz CG
Mov Disord; 1996 Jan; 11(1):24-6. PubMed ID: 8771063
[TBL] [Abstract][Full Text] [Related]
4. Report: Preparation of levodopa/carbidopa compound drug resins.
Liu H; Ding H; Zhang D; Fengsi -; Sun C
Pak J Pharm Sci; 2018 Jan; 31(1):205-211. PubMed ID: 29348105
[TBL] [Abstract][Full Text] [Related]
5. Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities.
Vemić A; Jančić Stojanović B; Stamenković I; Malenović A
J Pharm Biomed Anal; 2013 Apr; 77():9-15. PubMed ID: 23354116
[TBL] [Abstract][Full Text] [Related]
6. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
7. Quality control of benserazide-levodopa and carbidopa-levodopa tablets by capillary zone electrophoresis.
Fanali S; Pucci V; Sabbioni C; Raggi MA
Electrophoresis; 2000 Jul; 21(12):2432-7. PubMed ID: 10939456
[TBL] [Abstract][Full Text] [Related]
8. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
9. Levodopa microparticles for pulmonary delivery: photodegradation kinetics and LC stability-indicating method.
Pereira RL; Paim CS; Barth AB; Raffin RP; Guterres SS; Schapoval EE
Pharmazie; 2012 Jul; 67(7):605-10. PubMed ID: 22888517
[TBL] [Abstract][Full Text] [Related]
10. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease.
Stocchi F; Fabbri L; Vecsei L; Krygowska-Wajs A; Monici Preti PA; Ruggieri SA
Clin Neuropharmacol; 2007; 30(1):18-24. PubMed ID: 17272966
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of levodopa and carbidopa in levodopa-carbidopa tablets by ATR-FTIR spectrometry.
Khanmohammadi M; Mobedi E; Garmarudi AB; Mobedi H; Kargosha K
Pharm Dev Technol; 2007; 12(6):573-80. PubMed ID: 18161630
[TBL] [Abstract][Full Text] [Related]
14. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
[No Abstract] [Full Text] [Related]
15. Skin rash associated with Sinemet does not equal levodopa allergy.
Chou KL; Stacy MA
Neurology; 2007 Mar; 68(13):1078-9. PubMed ID: 17389317
[No Abstract] [Full Text] [Related]
16. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
17. Levodopa can worsen tremor associated with dystonia.
Hensman DJ; Bain PG
Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy.
Simsek T; Eryilmaz T; Acaroglu G
Int J Clin Pract; 2005 Mar; 59(3):287-90. PubMed ID: 15857324
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa.
Goole J; Van Gansbeke B; Pilcer G; Deleuze P; Blocklet D; Goldman S; Pandolfo M; Vanderbist F; Amighi K
Int J Pharm; 2008 Nov; 364(1):54-63. PubMed ID: 18778758
[TBL] [Abstract][Full Text] [Related]
20. Acute overdose with controlled-release levodopa-carbidopa.
Delmas G; Rothmann C; Flesch F
Clin Toxicol (Phila); 2008 Mar; 46(3):274-7. PubMed ID: 18344112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
